IOVA earnings call for the period ending June 30, 2019.
News & Analysis: Iovance Biotherapeutics, Inc.
These three biotech stocks might be outstanding buys right now.
The clinical-stage biopharma announced promising data at a major conference.
These three healthcare stocks could be outstanding additions to your portfolio.
Pfizer's acquisition of Array appeared to cause investors to wonder whether a big deal could be in store for Iovance.
Could the second half of the year be as much fun as the first?
There's more good news with the fight against cancer than you might think.
A great update at ASCO provided a spark for the biotech stock.
Can these high-flying biotech stocks keep the momentum going?
Good news gave these stocks even better gains than the overall market.